China’s JA Solar Sets Up Shop In Arizona as Year-Old Forced Labor Law Targets Its Supply Chain Back Home
Arizona gets $60 million solar plant. But the owner is China’s JA Solar, a company that will be in the cross hairs of forced labor laws.
Arizona gets $60 million solar plant. But the owner is China’s JA Solar, a company that will be in the cross hairs of forced labor laws.
By Charles Benoit, CPA Trade Counsel In December, the U.S.-China Commission, a group created by Congress to advise on managing the bilateral relationship, formally recommended that China lose its Most-Favored Nation (MFN) tariff status. Referencing the decision to grant China permanent MFN status in 2001, Speaker McCarthy said in remarks on the House floor yesterday…
Canadian Solar is mostly Chinese-run and produced. Its solar panels in a Maine government project may be tainted by forced labor.
U.S. pharmaceutical imports have skyrocketed in the last ten years, with imports from China, India and Mexico leading the surge.
A Department of Energy official warns that China’s outsized role in the solar industry is a headwind for Biden’s green energy plans, and energy security.
The November trade deficit fell, but that didn’t stop the U.S. from record imports this year. The goods deficit is now over $1.1 trillion.
Will China’s risk profile improve this year? By the looks of things, it will not. Some governments are divesting. For government fiduciaries, is it prudent to invest retirement accounts in China?
Online retailers don’t have to post where their products are made. Country of Origin labeling online would help people find US alternatives to imports.
There is a growing consensus in the U.S. and many other advanced economies that we must move away from globalization, and towards more localized economies, less reliant on global supply chains or untrustworthy countries for vital goods. Many can see the necessity for greater localization, but can’t imagine what it will look like. Will it…
A Senate Commerce subcommittee hearing heard from witnesses who said worker shortages will ultimately be a drag on U.S. reshoring efforts. Pharmaceutical reps warned of high energy costs, which could add to import dependence.